ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,3,Headache,Headaches NEC,Headaches,Nerv,N
1,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2,5,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2,8,Dysmetria,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,9,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,10,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2,11,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2,12,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2,13,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2,15,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2,16,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2,19,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,20,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2,21,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2,22,Saccadic eye movement,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2,23,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
4,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
5,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5,2,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
7,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
8,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
9,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Malaria,Plasmodia infections,Protozoal infectious disorders,Infec,N
10,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,1,Malaria,Plasmodia infections,Protozoal infectious disorders,Infec,N
11,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Malaria,Plasmodia infections,Protozoal infectious disorders,Infec,N
12,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Malaria,Plasmodia infections,Protozoal infectious disorders,Infec,N
13,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,2,Plasmodium falciparum infection,Plasmodia infections,Protozoal infectious disorders,Infec,N
14,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
15,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
16,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
16,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,3,Headache,Headaches NEC,Headaches,Nerv,N
16,4,Plasmodium malariae infection,Plasmodia infections,Protozoal infectious disorders,Infec,N
16,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,2,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
18,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
19,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,Y
